The rate of increase in drug prices has slowed as insurers and others use a variety of tactics to negotiate lower prices for consumers. Medication for hepatitis C and diabetes were among the drugs whose cost was most influenced by new pricing strategies. (Bloomberg Business)
Madlin Mekelburg was a reporting fellow for the Tribune in 2015 and 2016. She is a graduate of the University of Texas at Austin, where she studied journalism and French. Madlin previously worked at the... More by Madlin Mekelburg
